Marxa L. Figueiredo
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
121
Citations
1,492
Est. group size
~6
Recurring co-author estimate
Active years
30
Publishing since 1997
Marxa L. Figueiredo's research focuses on developing new therapies for cancer, especially prostate cancer and its spread to bone, using approaches like oncolytic viruses (viruses engineered to kill tumor cells), engineered immune cells (such as CAR-NK cells), and gene delivery methods. The lab also uses tools like single-cell RNA sequencing to study how tumors interact with the immune system, working across both human and veterinary (canine) cancer models.
Publication output has fluctuated over the past decade without a clear steady increase or decline, with a notable peak in 2025 following a smaller output in 2024.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Transcriptomic profiling reveals prognostic gene signatures and immune landscape alterations in canine diffuse large B-cell lymphoma
Veterinary oncology. · 2026
- Immunomodulation of the Prostate Tumor Microenvironment Following Inorganic Arsenic Exposure
Journal of Applied Toxicology · 2026
- Experimental models for developing oncolytic virotherapy for metastatic prostate cancer
Frontiers in Immunology · 2025
- Editorial: Tumor microenvironment complexity and its therapeutic implications
Frontiers in Veterinary Science · 2025
- Single-Cell RNA Sequencing Identifies CCR6-Driven Immune Landscape Changes in RM1 Prostate Cancer Bone Metastasis
DNA and cell biology reports. · 2025
- Introduction to polymers for gene delivery
Polymer Chemistry · 2025
- Abstract 5693: Diagnostic and predictive biomarkers for canine prostatic carcinoma: translational therapeutic insights
Cancer Research · 2025
- Correction: Experimental models for developing oncolytic virotherapy for metastatic prostate cancer
Frontiers in Immunology · 2025
- Halogenated N-(1,3,4-oxadiazol-2-yl) benzamides are effective eradicators of methicillin-resistant Staphylococcus aureus biofilms
Bioorganic & Medicinal Chemistry · 2025
- IL-27-engineered CAR.19-NK-92 cells exhibit enhanced therapeutic efficacy
Cytotherapy · 2024
- Applications of single-cell RNA sequencing in rheumatoid arthritis
Frontiers in Immunology · 2024
- IL-27 IN A FOURTH GENERATION CAR ENHANCES CAR-NK CELL EFFECTOR FUNCTION
Cytotherapy · 2024
- Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo
Frontiers in Immunology · 2023
- Is Osteopontin a Good Marker for Bone Metastasis in Canine Mammary Gland Tumor and Prostate Cancer?
Animals · 2023
- Global proteomics insights for a novel small compound targeting the non-integrin Laminin Receptor in a macrophage cell model
Frontiers in Drug Discovery · 2023
- The FASEB Journal×13
- Cancer Research×6
- Frontiers in Immunology×4
- Bioengineering×4
- Cytotherapy×3
- Saki Kondo
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Sanggu Kim
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Krystof S. Bankiewicz
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Kenneth Cornetta
Biochemistry, Genetics and Molecular Biology · Indiana University
- Piotr Hadaczek
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile